Omega Healthcare Investors, Inc. — FY2020 Form 10-K Summary
Business Context and Reporting Period
Omega is a Maryland REIT and UPREIT focused on healthcare-related real estate and financing, primarily skilled nursing facilities and assisted living facilities in the U.S. and U.K. The filing covers the fiscal year ended December 31, 2020, although the request references 2020 Q4. Omega had 967 facilities across 40 states and the U.K., operated by 69 third-party operators, with approximately $9.7 billion of real estate investments.
Leases are generally long-term triple-net leases, while mortgage investments are primarily fixed-rate loans secured by healthcare real estate. Omega owned approximately 97% of Omega OP at year-end.
Financial Performance and Key Metrics
| Metric | 2020 | 2019 | Change |
|---|---|---|---|
| Total revenues | $892.4 million | $928.8 million | Down $36.4 million |
| Rental income | $753.4 million | $804.1 million | Down $50.6 million |
| Mortgage interest income | $89.4 million | $76.5 million | Up $12.9 million |
| Total expenses | $734.9 million | $641.5 million | Up $93.5 million |
| Net income | $163.5 million | $351.9 million | Down 53.5% |
| Net income available to common stockholders | $159.3 million | $341.1 million | Down 53.3% |
| Diluted EPS | $0.70 | $1.58 | Down $0.88 |
| Nareit FFO | $555.9 million | $640.0 million | Down 13.1% |
| Cash flow from operations | $708.3 million | $553.7 million | Up $154.5 million |
| Dividends paid | $612.3 million | $564.1 million | Up $48.2 million |
Total assets were $9.5 billion, total equity was $4.0 billion, and total net debt was approximately $5.2 billion at December 31, 2020. Debt represented approximately 56.4% of total capitalization. Cash, cash equivalents and restricted cash totaled $167.6 million, compared with $33.4 million at year-end 2019.
Interest expense increased to $223.4 million from $208.7 million. Depreciation and amortization was $329.9 million, and impairment on real estate properties was $72.5 million. The filing does not provide a single GAAP operating-margin measure; based on reported figures, total expenses represented approximately 82.4% of revenue in 2020 versus approximately 69.0% in 2019.
Material Changes Versus the Prior Comparable Period
- Rental income declined primarily because four operators were placed on a cash basis and approximately $143.0 million of contractual receivables, straight-line rent receivables and lease inducements were written off. Genesis accounted for approximately $64.9 million and Agemo for approximately $75.3 million.
- Four operators reported substantial doubt regarding their ability to continue as going concerns during the third and fourth quarters of 2020.
- Provision for credit losses increased by $38.0 million, including the effect of adopting ASU 2016-13. The year-end allowance for credit losses was $67.8 million.
- Real estate impairments increased to approximately $72.5 million from $45.3 million, primarily reflecting exits from non-strategic facilities and operator relationships.
- Mortgage interest income increased due to new mortgages, additional operator funding and mortgages acquired in the 2019 MedEquities merger.
- Omega issued $700 million of 3.375% senior notes due 2031 and used the proceeds to repay its U.S. term loan and 2015 term loan and reduce other borrowings. Debt extinguishment costs totaled $13.3 million, including costs related to terminating interest-rate swaps.
- Omega invested approximately $258 million in 2020, including $104 million for eight SNFs and three ALFs, $43 million in two SNF mortgages and $111 million in capital expenditure and construction projects.
- Omega sold 43 facilities for approximately $180.9 million of net proceeds and recognized a net gain of approximately $19.1 million, compared with 34 facilities sold for $219.3 million and a $55.7 million gain in 2019.
- The company paid common dividends of $2.68 per share for 2020, including quarterly dividends of $0.67 per share. The filing notes that portions of historical dividends have represented a return of capital.
COVID-19, Outlook, Risks and Unusual Items
Omega collected substantially all contractual rents for 2020, but the pandemic materially affected its operators through increased labor, PPE, testing and infection-control costs and lower occupancy. As of February 9, 2021, operators reported COVID-19 cases at 535 of 949 operating facilities, or 56.4%; Omega cautioned that it had not independently validated this information.
Management expects near-term uncertainty to persist regarding occupancy recovery, operator costs, vaccine participation, government relief, reimbursement rates and potential requests for financial support from operators. Longer-term demographics are expected to support demand for needs-based skilled nursing care, but the timing of recovery to pre-pandemic occupancy levels remains uncertain.
- The $143.0 million receivable and lease-inducement write-off, the $37.997 million credit-loss provision and the $72.5 million real estate impairment charge were significant unusual or judgment-sensitive items.
- Omega restructured its Maplewood relationship, received a one-time $55.4 million rent payment and provided $34.1 million of lease-inducement funding to operators, including $23.9 million to Maplewood.
- Daybreak paid no rent in 2020. Omega transitioned 31 Daybreak facilities and expected to transition 14 more in 2021, with an expected eventual annual rent or rent equivalent of $15 million to $17 million.
- A $1.25 billion revolving credit facility had $101.2 million outstanding and matured on May 25, 2021, subject to extension options. Management expected to refinance or extend it by that date.
- Debt maturities totaled $130.9 million in 2021, $902.3 million in 2022-2023, and $816.5 million in 2024-2025. Interest payments on long-term debt were estimated at $1.42 billion over the contractual schedule.
- Remaining capital commitments were $106.4 million, excluding approximately $95.7 million of commitments under other investments.
- Variable-rate borrowings outstanding were approximately $287.9 million and $450 million of derivative notional value was indexed to LIBOR. The filing identifies LIBOR transition as a potential cost and execution risk.
- Subsequent to year-end, Omega acquired 24 senior living facilities for $510 million with approximately $43.5 million of 2021 contractual rent. In February 2021, it sold 16 facilities for approximately $149.6 million and recognized a gain of approximately $94.4 million.
- Omega disclosed a pending securities class action and related derivative actions concerning disclosures about operator financial condition and rent collectibility. A Department of Justice investigation also concerns alleged False Claims Act, Stark Law and Anti-Kickback Statute issues involving Lakeway Hospital; the filing states that the potential loss cannot currently be determined.
Most Important Facts for Investors to Verify
- Whether operator occupancy, labor costs, reimbursement and cash rent collections recover sufficiently as COVID-19 effects diminish.
- The financial condition, restructuring status and payment capacity of Genesis, Agemo, Maplewood and other financially stressed operators.
- Refinancing or extension of the revolving credit facility and the company’s ability to address 2021-2025 debt maturities without reducing investment capacity or dividends.
- The sustainability of the $0.67 quarterly dividend relative to recurring cash flow and Nareit FFO, including the portion characterized as return of capital.
- Whether additional credit-loss provisions, impairments, cash-basis accounting changes or operator support will be required.
- The outcome and potential exposure from the securities litigation, derivative actions and Lakeway-related DOJ investigation.
- Progress on asset sales, Daybreak transitions, held-for-sale properties and the integration and performance of the January 2021 acquisition.
- Compliance with REIT qualification requirements, debt covenants, healthcare reimbursement regulations and changing infection-control and quality-of-care requirements.